TABLE 1

SPM Results for Clusters of Difference in mGluR5 Availability Between Cocaine and Sucrose Group

Cluster levelVoxel levelCoordinate
ParameterThreshold (P)PCorrKE∆S (%)∆C (%)TPCorrxyzAnatomic structure
Baseline > DE20.00001 (FWE)0.00011,6313−147.900.00012.1−0.95.2CPU L, NAC L, AI L, OC L
0.0001780−0−157.820.0001−2.3−0.85.0CPU R, NAC R
0.0001397−3−166.850.0001−5.5−1.06.5AI L, OC L
0.0001439−2−156.690.0001−5.2−6.86.7Hippocampus R (CA1, S)
0.00012340−136.340.0001−5.2−5.87.2Hippocampus L (CA1, S)
Baseline > W20.00001 (FWE)0.00015020−157.670.0001−2.3−0.85.0CPU L, NAC L
0.00017015−147.650.00012.1−0.54.7CPU R, NAC R
Baseline > relapse0.00001 (FWE)0.00012,478−0−249.670.0001−2.3−0.85.0CPU L, NAC L, AI L, OC L
0.00012,8920−139.340.00012.1−0.75.1CPU R, NAC R, AI R, OC R
0.0001387−5−156.890.00015.2−6.86.7Hippocampus R (CA1, S)
0.0001387−7−136.690.0001−6.0−6.06.0Hippocampus L (CA1, S, DG)
  • DE2 = drug-exposure week 2; W2 = withdrawal week 2; FWE = familywise error–corrected; KE = cluster extent; ∆S = percentage change between respective phases for sucrose group; ∆C = percentage change between respective phases for cocaine group; T = T-score value; CPU = striatum; NAC = nucleus accumbens; AI = agranular insular cortex; OC = orbital cortex; S = subiculum; DG = dentate gyrus.